TABLE 1.
Clinical laboratory results
| Measure | Reference range | Baseline 2019/12/4 | Fever clinic 2020/2/2 | D2 2020/2/5 | D6 2020/2/9 | D9 2020/2/12 | D11 2020/2/14 |
|---|---|---|---|---|---|---|---|
| ALT (U/L) | ≤41 | 20 | 30 | 74 | 94 | 61 | |
| AST (U/L) | ≤40 | 22 | 29 | 41 | 33 | 23 | |
| Albumin (g/L) | 35-52 | 46.7 | 35.2 | 36.3 | 34.6 | 35.7 | |
| IgG (g/L) | 20-35 | 29.6 | 31.7 | 34.8 | 42.2 | 42.3 | |
| BUN (mmol/L) | 3.1-8.0 | 6.59 | 7.8 | 5.8 | 8.5 | 8 | |
| SCr (µmol/L) | 59-104 | 139 | 143 | 112 | 112 | 104 | |
| eGFR (mL/min/1.73m2) | >90 | 49.8 | 48.2 | 64.7 | 64.7 | 70.8 | |
| CRP (mg/L) | <3.0 | 30.2 | 54.0 | 29.8 | 3.0 | 1.4 | |
| WBC (×109/L) | 3.50-9.50 | 6.97 | 9.16 | 5.54 | 6.46 | 10.36 | 11.68 |
| NEUT (%) | 40.0-75 | 61.6 | 78.3 | 68.9 | 72.9 | 78.9 | 80.9 |
| NEUT (×109/L) | 1.8-6.3 | 4.29 | 7.17 | 3.82 | 4.71 | 8.17 | 9.45 |
| LYM (%) | 20.0-50.0 | 30.4 | 12.3 | 17.9 | 15.6 | 13.2 | 12.0 |
| LYM (×109/L) | 1.10-3.20 | 2.12 | 1.13 | 0.99 | 1.01 | 1.37 | 1.40 |
| MONO (%) | 3.0-10 | 6.9 | 9.5 | 13.0 | 11.3 | 7.8 | 6.9 |
| MONO (×109/L) | 0.1-0.6 | 0.48 | 0.84 | 0.72 | 0.73 | 0.81 | 0.81 |
| PLT (×109/L) | 125-350 | 190 | 126 | 125 | 199 | 354 | 367 |
| Urine protein | Negative | Negative | 1+ | Trace | |||
| Urine gravity | 1.101-1.025 | 1.022 | 1.022 | 1.016 | |||
| IL-1beta (pg/mL) | <5.0 | <5.0 | |||||
| IL-2 receptor (U/mL) | 223-710 | 863 | |||||
| IL-6 (pg/mL) | <7 | 19.53 | |||||
| IL-8 (pg/mL) | <62 | 9.6 | |||||
| IL-10 (pg/mL) | <9.1 | <5.0 | |||||
| TNF alpha | <8.1 | 13.1 |
Note: Values in bold were either above normal or below normal.
Abbreviations: ALT, alanine aminotransferase; AST, aspartate aminotransferase; BUN, blood urea nitrogen; CRP, C-reactive protein; eGFR, estimated glomerular filtration rate, based on CKD-EPI creatinine 2009 equation method; IL, interleukin; LYM, lymphocyte; MONO, monocyte; NEUT, neutrophil; PLT, platelet; SCr, serum creatinine; TNF, tumor necrosis factor; WBC, white blood cell.